Effect of Roflumilast in airways disorders via dual inhibition of phosphodiesterase and Ca2+-channel
The bronchodilator effects of Roflumilast “a selective phosphodiesterase type-4 (PDE4)” inhibitor studied in this experimental protocol. The spiral strips of isolated guinea-pig tracheal chains mounted in organ bath and maintained in Krebs solution ventilated with carbogen at 32 °C and in Ca++ restr...
Main Authors: | Faisal Imam, Najeeb Ur Rehman, Mohd Nazam Ansari, Wajhul Qamar, Muhammad Afzal, Khalid Saad Alharbi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Saudi Pharmaceutical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S131901642030089X |
Similar Items
-
Roflumilast – a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD
by: Anne B Taegtmeyer, et al.
Published: (2012-07-01) -
Characterization of Resveratrol, Oxyresveratrol, Piceatannol and Roflumilast as Modulators of Phosphodiesterase Activity. Study of Yeast Lifespan
by: Adrián Matencio, et al.
Published: (2020-08-01) -
Dual Inhibition of Phosphodiesterase and Ca<sup>++</sup> Channels Explains the Medicinal Use of <i>Balanites aegyptiaca</i> (L.) in Hyperactive Gut Disorders
by: Najeeb Ur Rehman, et al.
Published: (2022-04-01) -
Roflumilast tópico y oral en dermatología. Una revisión narrativa
by: M. Mansilla-Polo, et al.
Published: (2024-03-01) -
Effects of Roflumilast, Selective PDE4 Inhibitor, on Airway Reactivity in Ovalbumin-Sensitized Guinea Pigs
by: Tharmalingam Nirmathan, et al.
Published: (2015-05-01)